These studies demonstrated that the levels of serum SDF-1 were increased in patients with diabetes mellitus, and increased SDF-1 can aggravate insulin resistance, and promote chronic inflammation and immune responses, which are the main mechanisms of diabetes mellitus progression and diabetes-associated cardiovascular events [12–15]. The gene discussed is CXCL12; the disease is diabetes mellitus.